NNW Headlines
Save 20% on Press Releases and More with NNW Prime! Click to View Details
Home » NewsRoom » NewsRoom Articles
MondayFeb 17, 2020 12:30 pm

Educational Development Corp. (NASDAQ: EDUC) Starts Presentation at NobleCon16

Educational Development (NASDAQ: EDUC) (“EDC”) is a publishing company specializing in books for children.  EDC is the exclusive United States trade co-publisher of the line of educational children’s books produced in the United Kingdom by Usborne Publishing Limited, and also exclusively publishes books through its ownership of Kane Miller Book Publisher – both of which are international award-winning publishers of children’s books. EDC’s current catalog contains over 2,000 titles, with new additions semi-annually. Both Usborne and Kane Miller products are sold via 4,000 retail outlets and by independent consultants, who hold book showings in individual homes, through social media, book…

Continue Reading

MondayFeb 17, 2020 12:30 pm

International Seaways Inc. (NYSE: INSW) Starts Presentation at NobleCon16

International Seaways (NYSE: INSW) is one of the largest tanker companies worldwide providing energy transportation services for crude oil and petroleum products in International Flag markets. International Seaways owns and operates a fleet of 42 vessels, including 13 VLCCs, two Suezmaxes, six Aframaxes/LR2s, 12 Panamaxes/LR1s and seven MR tankers. Through joint ventures, International Seaways currently has ownership interests in two floating storage and offloading service vessels. The company has an experienced team committed to the highest operating practices and the highest levels of customer service and operational efficiency. For more information, visit the company’s website at www.intlseas.com About NetworkNewsWire NetworkNewsWire…

Continue Reading

MondayFeb 17, 2020 12:30 pm

Matinas BioPharma Inc. (NYSE: MTNB) Starts Presentation at NobleCon16

Matinas BioPharma (NYSE: MTNB) is a clinical-stage biopharmaceutical company focused on development of its lead product candidate, MAT9001, for the treatment of cardiovascular and metabolic conditions. MAT9001 is a prescription-only omega-3 fatty acid-based composition, comprised primarily of EPA and DPA, under development for hypertriglyceridemia, that was specifically designed to overcome the shortcomings seen from other agents in the omega-3 class. Matinas BioPharma is also developing MAT2203, an oral, encochleated formulation of amphotericin B, to treat serious invasive fungal infections. The drug is based on the company’s proprietary lipid nano-crystal (LNC) platform technology which can help solve complex challenges relating to…

Continue Reading

MondayFeb 17, 2020 12:00 pm

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI) Starts Presentation at NobleCon16

BrainStorm Cell Therapeutics (NASDAQ: BCLI) is a leading developer of innovative autologous adult stem cell therapeutics for debilitating neurodegenerative diseases. The company holds the rights to clinical development and commercialization of the NurOwn® Cellular Therapeutic Technology Platform used to produce autologous MSC-NTF cells through an exclusive, worldwide licensing agreement as well as through its own patents, patent applications and proprietary know-how. Autologous MSC-NTF cells have received Orphan Drug status designation from the U.S. Food and Drug Administration (U.S. FDA) and the European Medicines Agency (EMA) for ALS. Brainstorm has fully enrolled the phase 3 pivotal trial in ALS (NCT03280056), investigating repeat-administration of autologous MSC-NTF cells at six…

Continue Reading

MondayFeb 17, 2020 12:00 pm

Ely Gold Royalties Inc. (TSX.V: ELY) (OTCQB: ELYGF) Starts Presentation at NobleCon16

Ely Gold Royalties (TSX.V: ELY) (OTCQB: ELYGF) is an emerging royalty company with development assets focused in Nevada and Quebec. Its current portfolio includes 35 deeded royalties and 21 properties optioned to third parties. Ely Gold's royalty portfolio includes producing royalties, fully permitted mines and development projects that are at or near producing mines. The company is actively seeking opportunities to purchase existing third-party royalties for its portfolio and all the company's option properties are expected to produce royalties, if exercised. The royalty and option portfolios are currently generating significant revenue. Ely Gold is well positioned with its current portfolio…

Continue Reading

MondayFeb 17, 2020 12:00 pm

ISG (Information Services Group) (NASDAQ: III) Starts Presentation at NobleCon16

ISG (Information Services Group) (NASDAQ: III) is a leading global technology research and advisory firm with more than 700 clients, including more than 70 of the Top 100 enterprises in the world. The firm specializes in digital transformation services, including automation, cloud and data analytics; sourcing advisory; managed governance and risk services; network carrier services; strategy and operations design; change management; market intelligence and technology research and analysis. Founded in 2006, and based in Stamford, Conn., ISG employs more than 1,300 digital-ready professionals operating in more than 20 countries—a global team known for its innovative thinking, market influence, deep industry…

Continue Reading

MondayFeb 17, 2020 12:00 pm

Trovagene Inc. (NASDAQ: TROV) Starts Presentation at NobleCon16

Trovagene (NASDAQ: TROV) is a clinical-stage Precision Cancer Medicine™ oncology therapeutics company developing drugs that target cell division (mitosis), for the treatment of various cancers including solid tumors, leukemias and lymphomas. Trovagene has intellectual property and proprietary technology that enables the company to analyze circulating tumor DNA (ctDNA) and clinically actionable markers to identify patients most likely to respond to specific cancer therapies. Trovagene plans to continue to vertically integrate its tumor genomics technology with the development of targeted cancer therapeutics. For more information, visit the company’s website at https://www.trovageneoncology.com About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company…

Continue Reading

MondayFeb 17, 2020 11:30 am

Applied Energetics Inc. (AERG) Starts Presentation at NobleCon16

Applied Energetics (OTCQB: AERG) (“AE”) specializes in the development and manufacture of advanced high-performance lasers, high voltage electronics, advanced optical systems, and integrated guided energy systems for defense, aerospace, industrial and scientific customers worldwide. AE has pioneered and holds all crucial intellectual property rights to the development and use of Laser Guided Energy (LGETM) technology and related solutions for commercial, defense and security applications, protected by 26 patents and 11 additional Government Sensitive Patent Applications “GSPA.” The company’s 11 GSPA’s are held under secrecy orders of the U.S. government and allow AE greatly extended protection rights. For more information, visit the company’s…

Continue Reading

MondayFeb 17, 2020 11:30 am

Indonesia Energy Corporation Ltd. (NYSE: INDO) Starts Presentation at NobleCon16

Indonesia Energy (NYSE: INDO) is engaged in the acquisition and development of strategic, high growth energy projects in Indonesia. The company’s strategy is to build an oil and gas assets portfolio with an optimum mix between medium-sized producing blocks and exploration blocks with significant potential resources. IEC's principal assets are its Kruh Block (63,000 acres) located onshore on the Island of Sumatra in Indonesia and its Citarum Block (1,000,000 acres) located onshore on the Island of Java in Indonesia. IEC is headquartered in Jakarta, Indonesia and has a representative office in Danville, California. For more information, visit the company’s website…

Continue Reading

MondayFeb 17, 2020 11:30 am

Aeterna Zentaris Inc. (TSX: AEZS) (NASDAQ: AEZS) Starts Presentation at NobleCon16

Aeterna Zentaris (NASDAQ: AEZS) (TSX: AEZS) is a specialty biopharmaceutical company engaged in commercializing novel pharmaceutical therapies, principally through out-licensing arrangements. Aeterna Zentaris is the licensor and party to a license and assignment agreement with Novo Nordisk A/S to carry out joint development, manufacturing, registration, regulatory, and supply chain for the commercialization of Macrilen™ (macimorelin), for use in the diagnosis of patients with adult growth hormone deficiency in the United States and Canada. The clinical development of Macrilen(TM) for pediatric use is ongoing. Aeterna Zentaris is actively pursuing business development opportunities for Macrilen(TM) in the rest of the world and…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000

NetworkNewsWire

1108 Lavaca St
Suite 110-NNW
Austin, TX 78701
(512) 354-7000

NetworkNewsWire is powered by IBNAi

Copyright . NetworkNewsWire® / 1108 Lavaca St Suite 110-NNW Austin, TX 78701 (512) 354-7000 / Disclaimers